Last 12 months
Inside the activity.
0 purchase rows · 63 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 29 |
| Jan 2026 | 0 | 10 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 05, 2023 Filed May 8, 2023 21:25 UTC |
Granat JillSee Remarks
|
Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $27.28 | $0.00 |
DisclosureSEC source: 0001209191-23-028020 · doc4.xml · derivative · entry 9 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 15,000 shares Expires 2024-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| May 05, 2023 Filed May 8, 2023 21:25 UTC |
Granat JillSee Remarks
|
Exercise / conversionOption (right to buy) · Derivative | 15,945 | $0.00 Strike: $27.28 | $0.00 |
DisclosureSEC source: 0001209191-23-028020 · doc4.xml · derivative · entry 7 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 15,945 shares Expires 2024-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| May 05, 2023 Filed May 8, 2023 21:25 UTC |
Granat JillSee Remarks
|
SaleCommon Shares | 30,945 | $71.25 | $2,204,831.25 |
DisclosureSEC source: 0001209191-23-028020 · doc4.xml · nonDerivative · entry 5 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 342,059.3047 F2 · price: Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transaction ranged from $71.01 to $71.49 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Read SEC document |
| May 05, 2023 Filed May 8, 2023 21:25 UTC |
Granat JillSee Remarks
|
Exercise / conversionCommon Shares | 15,000 | $27.28 | $409,200.00 |
DisclosureSEC source: 0001209191-23-028020 · doc4.xml · nonDerivative · entry 4 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 373,004.3047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2023 Filed May 8, 2023 21:25 UTC |
Granat JillSee Remarks
|
Exercise / conversionCommon Shares | 15,945 | $27.28 | $434,979.60 |
DisclosureSEC source: 0001209191-23-028020 · doc4.xml · nonDerivative · entry 3 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 358,004.3047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2023 Filed May 8, 2023 21:27 UTC |
Schwan AxelPres., Tim Hortons Americas
|
SaleCommon Shares | 34,000 | $71.25 | $2,422,500.00 |
DisclosureSEC source: 0001209191-23-028024 · doc4.xml · nonDerivative · entry 1 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,304.5726 F1 · price: Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transaction ranged from $71.25 to $71.28 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price. Read SEC document |
| May 04, 2023 Filed May 8, 2023 17:26 UTC |
Shear David ChanPresident, International
|
Exercise / conversionOption (right to Buy) · Derivative | 40,000 | $0.00 Strike: $58.44 | $0.00 |
DisclosureSEC source: 0001209191-23-028021 · doc4.xml · derivative · entry 7 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 40,000 shares Expires 2028-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2023 Filed May 8, 2023 17:26 UTC |
Shear David ChanPresident, International
|
Exercise / conversionOption (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $55.55 | $0.00 |
DisclosureSEC source: 0001209191-23-028021 · doc4.xml · derivative · entry 6 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 100,000 shares Expires 2027-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are immediately exercisable. Read SEC document |
| May 04, 2023 Filed May 8, 2023 17:26 UTC |
Shear David ChanPresident, International
|
SaleCommon Shares | 11,210 | $71.12 | $797,243.99 |
DisclosureSEC source: 0001209191-23-028021 · doc4.xml · nonDerivative · entry 4 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,250.4332 F2 · price: Represents the weighted average price of the shares sold. The reported shares were sold at prices ranging from $70.99 to $71.27 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Read SEC document |
| May 04, 2023 Filed May 8, 2023 17:26 UTC |
Shear David ChanPresident, International
|
SaleCommon Shares | 128,790 | $70.62 | $9,095,149.80 |
DisclosureSEC source: 0001209191-23-028021 · doc4.xml · nonDerivative · entry 3 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,460.4332 F1 · price: Represents the weighted average price of the shares sold. The reported shares were sold at prices ranging from $69.99 to $70.985 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Read SEC document |
| May 04, 2023 Filed May 8, 2023 17:26 UTC |
Shear David ChanPresident, International
|
Exercise / conversionCommon Shares | 40,000 | $58.44 | $2,337,600.00 |
DisclosureSEC source: 0001209191-23-028021 · doc4.xml · nonDerivative · entry 2 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 315,250.4332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2023 Filed May 8, 2023 17:26 UTC |
Shear David ChanPresident, International
|
Exercise / conversionCommon Shares | 100,000 | $55.55 | $5,555,000.00 |
DisclosureSEC source: 0001209191-23-028021 · doc4.xml · nonDerivative · entry 1 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,250.4332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2023 Filed May 8, 2023 21:25 UTC |
Granat JillSee Remarks
|
Exercise / conversionOption (right to buy) · Derivative | 25,000 | $0.00 Strike: $27.28 | $0.00 |
DisclosureSEC source: 0001209191-23-028020 · doc4.xml · derivative · entry 8 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Shares · 25,000 shares Expires 2024-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| May 04, 2023 Filed May 8, 2023 21:25 UTC |
Granat JillSee Remarks
|
SaleCommon Shares | 25,000 | $70.18 | $1,754,500.00 |
DisclosureSEC source: 0001209191-23-028020 · doc4.xml · nonDerivative · entry 2 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 342,059.3047 F1 · price: Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transaction ranged from $70.02 to $70.51 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Read SEC document |
| May 04, 2023 Filed May 8, 2023 21:25 UTC |
Granat JillSee Remarks
|
Exercise / conversionCommon Shares | 25,000 | $27.28 | $682,000.00 |
DisclosureSEC source: 0001209191-23-028020 · doc4.xml · nonDerivative · entry 1 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 367,059.3047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:08 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 183.9426 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023820 · doc4.xml · derivative · entry 16 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,323.9426 Underlying: Common Shares · 183.9426 shares Expires 2026-02-22 F14 · derivative.exercise_price: The shares reported represents an award of performance based restricted share units (the "2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:08 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 77.5816 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023820 · doc4.xml · derivative · entry 15 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,415.5816 Underlying: Common Shares · 77.5816 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:08 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 212.9035 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023820 · doc4.xml · derivative · entry 14 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,838.742 Underlying: Common Shares · 212.9035 shares Expires 2025-02-25 F12 · derivative.exercise_price: The shares reported represents an award of performance based restricted share units (the "2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:08 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 76.8246 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023820 · doc4.xml · derivative · entry 13 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,323.7104 Underlying: Common Shares · 76.8246 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F11 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:08 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 19.4596 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023820 · doc4.xml · derivative · entry 12 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,361.6872 Underlying: Common Shares · 19.4596 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:08 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 111.5291 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023820 · doc4.xml · derivative · entry 11 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,535.5757 Underlying: Common Shares · 111.5291 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:08 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 186.078 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023820 · doc4.xml · derivative · entry 10 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,583.1082 Underlying: Common Shares · 186.078 shares Expires 2025-02-21 F9 · derivative.exercise_price: The shares reported represents an award of performance based restricted share units (the "2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:08 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 22.8504 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023820 · doc4.xml · derivative · entry 9 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,773.2057 Underlying: Common Shares · 22.8504 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F8 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:08 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 287.4807 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023820 · doc4.xml · derivative · entry 7 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,889.7025 Underlying: Common Shares · 287.4807 shares Expires 2024-02-22 F6 · derivative.exercise_price: The shares reported represent an award of performance base restricted share units (the "2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2024, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:08 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 28.9014 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023820 · doc4.xml · derivative · entry 6 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,507.5781 Underlying: Common Shares · 28.9014 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 17:11 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 613.142 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023825 · doc4.xml · derivative · entry 17 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,413.142 Underlying: Common Shares · 613.142 shares Expires 2026-02-22 F17 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 25, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 17:11 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 182.5302 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023825 · doc4.xml · derivative · entry 16 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,152.5302 Underlying: Common Shares · 182.5302 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F16 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F16 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 17:11 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 510.9752 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023825 · doc4.xml · derivative · entry 15 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,013.8106 Underlying: Common Shares · 510.9752 shares Expires 2025-02-25 F15 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 17:11 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 122.8538 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023825 · doc4.xml · derivative · entry 14 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,909.9803 Underlying: Common Shares · 122.8538 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F14 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F14 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 17:11 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 298.898 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023825 · doc4.xml · derivative · entry 13 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,275.3429 Underlying: Common Shares · 298.898 shares Expires 2024-02-19 F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 17:11 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 47.7345 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023825 · doc4.xml · derivative · entry 12 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,793.2264 Underlying: Common Shares · 47.7345 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 17:11 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 49.0728 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023825 · doc4.xml · derivative · entry 11 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,955.6533 Underlying: Common Shares · 49.0728 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F11 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 17:11 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 180.009 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023825 · doc4.xml · derivative · entry 10 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,846.5422 Underlying: Common Shares · 180.009 shares Expires 2025-02-21 F10 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units (the "2020-2 PBRSUs") granted to the Reporting Person. The 2020-2 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 17:11 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 232.5976 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023825 · doc4.xml · derivative · entry 9 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,228.8852 Underlying: Common Shares · 232.5976 shares Expires 2025-02-21 F9 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units (the "2020-1 PBRSUs") granted to the Reporting Person. The 2020-1 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 17:11 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 56.1211 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023825 · doc4.xml · derivative · entry 8 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,811.0654 Underlying: Common Shares · 56.1211 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F8 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 17:11 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 479.1345 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023825 · doc4.xml · derivative · entry 6 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,149.5042 Underlying: Common Shares · 479.1345 shares Expires 2024-02-22 F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units (the "2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2024, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 17:11 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 81.0983 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023825 · doc4.xml · derivative · entry 5 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,842.3851 Underlying: Common Shares · 81.0983 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:15 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantPerformance Share Units · Derivative | 367.8852 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023834 · doc4.xml · derivative · entry 9 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,647.8852 Underlying: Common Shares · 367.8852 shares Expires 2026-02-22 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:15 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantRestricted Share Units · Derivative | 75.4879 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023834 · doc4.xml · derivative · entry 8 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,161.4879 Underlying: Common Shares · 75.4879 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:15 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantPerformance Share Units · Derivative | 340.6473 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023834 · doc4.xml · derivative · entry 7 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,342.1946 Underlying: Common Shares · 340.6473 shares Expires 2025-02-25 F9 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:15 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantRestricted Share Units · Derivative | 59.1582 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023834 · doc4.xml · derivative · entry 6 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,179.6549 Underlying: Common Shares · 59.1582 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F8 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:15 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantPerformance Share Units · Derivative | 130.5597 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023834 · doc4.xml · derivative · entry 5 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,845.198 Underlying: Common Shares · 130.5597 shares Expires 2024-12-15 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021-2 PBRSUs") granted to the Reporting Person. The 2021-2 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on December 15, 2024, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:15 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantRestricted Share Units · Derivative | 87.0398 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023834 · doc4.xml · derivative · entry 4 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,563.4653 Underlying: Common Shares · 87.0398 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2022, December 15, 2023 and December 15, 2024. F6 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2022, December 15, 2023 and December 15, 2024. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:15 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantPerformance Share Units · Derivative | 131.6767 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023834 · doc4.xml · derivative · entry 3 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,980.7582 Underlying: Common Shares · 131.6767 shares Expires 2024-09-01 F4 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021-1 PBRSUs") granted to the Reporting Person. The 2021-1 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on September 1, 2024, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:15 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantRestricted Share Units · Derivative | 66.3802 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023834 · doc4.xml · derivative · entry 2 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,056.1384 Underlying: Common Shares · 66.3802 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F3 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F3 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:09 UTC |
DOYLE J PATRICKDirector · Executive Chairman
|
GrantPerformance Share Units · Derivative | 6,283.2853 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023823 · doc4.xml · derivative · entry 4 DOYLE J PATRICK · CIK 0001337160 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 762,562.3551 Underlying: Common Shares · 6,283.2853 shares Expires not disclosed F5 · derivative.exercise_price: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending March 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. F5 · derivative.exercise_date: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending March 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. F5 · derivative.expiration_date: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending March 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:09 UTC |
DOYLE J PATRICKDirector · Executive Chairman
|
GrantRestricted Share Units · Derivative | 4,188.8569 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023823 · doc4.xml · derivative · entry 3 DOYLE J PATRICK · CIK 0001337160 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 508,374.9034 Underlying: Common Shares · 4,188.8569 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest in equal installments on November 21, 2023, November 21, 2024, November 21, 2025, November 21, 2026 and November 21, 2027. F4 · derivative.expiration_date: These restricted share units vest in equal installments on November 21, 2023, November 21, 2024, November 21, 2025, November 21, 2026 and November 21, 2027. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:13 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 275.9139 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023830 · doc4.xml · derivative · entry 20 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,485.9139 Underlying: Common Shares · 275.9139 shares Expires 2026-02-22 F16 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:13 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 119.2221 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023830 · doc4.xml · derivative · entry 19 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,469.2221 Underlying: Common Shares · 119.2221 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F15 · derivative.exercise_date: The restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F15 · derivative.expiration_date: The restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 21:13 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 298.0717 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023830 · doc4.xml · derivative · entry 18 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,175.0686 Underlying: Common Shares · 298.0717 shares Expires 2025-02-25 F14 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.